Stay updated on XmAb®20717 in Selected Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.

Latest updates to the XmAb®20717 in Selected Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page footer now displays 'Revision: v3.3.3', and the 'HHS Vulnerability Disclosure' link along with the previous 'Revision: v3.3.2' text were removed.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision history now includes a new entry v3.3.2 and replaces v3.3.1, reflecting a minor site update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision (v3.3.1) replaces the previous revision (v3.2.0) on the page history, which appears to be a UI/version update rather than an alteration to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedRemoved the general government funding/operating status notice from the page, which does not affect trial data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check67 days agoChange DetectedThe history now shows updated entries for changes to the study status, recruitment details, and locations. These entries capture when and what changed.SummaryDifference0.1%

- Check95 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference12%

Stay in the know with updates to XmAb®20717 in Selected Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.